News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Markets were largely unchanged in the hour as news flow remained light.
  • No major economic data or central bank announcements were released in the past hour.
  • No new developments reported in major geopolitical conflicts or trade talks.
  • No major corporate earnings or M&A headlines emerged during the hour.
  • Oil and gold prices were flat amid absent market-moving news.

Latest Articles

Valero Ahead of Q2: Quality Refining, But Earnings Need to Prove It

Valero Ahead of Q2: Quality Refining, But Earnings Need to Prove It

Valero is a high-quality refiner sitting on robust margins and cash generation, but near-term execution on throughput and repair timelines will decide whether the stock reclaims its recent highs. This trade idea outlines a mid-term long setup that buys a manageable pullback ahead of/after the Q2 report, with a disciplined stop and concrete target.

Netflix vs Disney: weighing valuation safety against operational strength

Netflix vs Disney: weighing valuation safety against operational strength

Investors comparing Netflix and Walt Disney find two divergent pictures: Disney trades at a noticeably lower valuation and offers dividend resumption and lower volatility, but has a weak current ratio and recent cash-flow decline. Netflix shows superior profitability, gross margins, ROE, and large free cash flow, yet trades at a higher multiple and…

KLA posts solid Q4 but guidance cools investor enthusiasm

KLA posts solid Q4 but guidance cools investor enthusiasm

KLA Corporation reported fiscal Q4 FY2026 revenue of $3.66 billion, up 15% year-over-year, and adjusted EPS of $1.05 versus a $1.00 consensus. Despite the beat, shares slid after management set a guidance range that fell short of the market's lofty expectations. The quarter confirmed several growth elements, including robust advanced packaging reve…

Casablanca stocks dip as utilities, banking and mining pull index down

Casablanca stocks dip as utilities, banking and mining pull index down

Morocco's equity market finished lower on Wednesday, with the Moroccan All Shares index down 0.34% at the close in Casablanca. Declines in the Utilities, Banking and Mining sectors outpaced gains in select names, while crude and Brent oil rallied and gold futures slipped. Market breadth favored decliners, with 31 issues falling, 24 rising and 9 unc…

Bank of Mozambique Keeps MIMO Rate at 9.25% as Inflation Pressures Persist

Bank of Mozambique Keeps MIMO Rate at 9.25% as Inflation Pressures Persist

The Bank of Mozambique left its MIMO policy rate unchanged at 9.25% on Wednesday, marking the third straight meeting without adjustment. Inflation accelerated to 7.51% in June from 7.22% in May and officials flagged elevated risks from higher fuel prices, growing debt levels, climate-related shocks and the conflict in the Middle East. The central b…

Options Point to Roughly 6.3% Move for Disney Ahead of August Results

Options Point to Roughly 6.3% Move for Disney Ahead of August Results

Options market pricing implies Walt Disney Co. (DIS) shares could move about 6.3% around the company’s August 5 earnings report, reflecting the degree of uncertainty traders are pricing in for the pre-market release. Historical comparisons show mixed accuracy for options-implied moves across the past eight Disney earnings announcements.

Oslo benchmarks climb as healthcare, pharma and utilities lead gains

Oslo benchmarks climb as healthcare, pharma and utilities lead gains

Norwegian equities closed higher on Wednesday, with the Oslo OBX gaining 0.63% as strength in Healthcare Equipment & Services, Pharma Biotech & Life Sciences and Utilities supported the market. Large-cap energy stocks were among the session's top performers while select technology and shipping names declined. Commodity markets saw notable gains in …

Michigan Cyclosporiasis Tally Tops 10,000 as Investigation Continues

Michigan Cyclosporiasis Tally Tops 10,000 as Investigation Continues

Michigan health authorities reported 10,077 cases of cyclosporiasis, marking an increase of 397 cases from their previous daily update. Federal investigators have linked the outbreak to iceberg lettuce served at Taco Bell restaurants that originated from Taylor Farms operations in central Mexico, but health agencies continue seeking other potential…

Devon Energy Shares Jump as Investors Position Ahead of Q2 Results

Devon Energy Shares Jump as Investors Position Ahead of Q2 Results

Devon Energy climbed 3.3% to $44.08 in morning trading as investors built positions ahead of the company’s second-quarter 2026 report, due August 4 after the market close. Analysts forecast quarterly EPS near $1.30, about a 55% increase year over year, and Devon’s record of beating estimates in each of the last four quarters underpins investor conf…

SCWorx Receives Nasdaq Hearings Panel Partial Compliance Letter for the Company’s Continued Listing on the Nasdaq Capital Market

SCWorx Receives Nasdaq Hearings Panel Partial Compliance Letter for the Company’s Continued Listing on the Nasdaq Capital Market

SCWorx Corp. announced it has received a partial compliance letter from the Nasdaq Hearings Panel confirming that it has met the first requirement to maintain its listing on the Nasdaq Capital Market by achieving the minimum bid price for 20 consecutive trading days. The company continues to execute its compliance plan focused on satisfying all Nas…

The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy

The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy

Capricor Therapeutics announced that The Lancet has published its Phase 3 HOPE-3 clinical trial results showing Deramiocel significantly slows disease progression in Duchenne Muscular Dystrophy (DMD) patients. The trial met its primary endpoint, demonstrating a 54% slowing of upper limb function decline and cardiac benefits. The company’s Biologics…

Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and procedural innovation

Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and procedural innovation

Smith+Nephew announced that the FDA has granted De Novo classification to its TESSA Spatial Surgery System, an innovative technology that utilizes AI, advanced imaging, and real-time tracking to improve precision in arthroscopic surgeries such as anterior cruciate ligament reconstruction. This regulatory milestone establishes a new FDA category and…

Parsons Plunges After Earnings Miss, $118M of Charges and Deep Guidance Cut

Parsons Plunges After Earnings Miss, $118M of Charges and Deep Guidance Cut

Parsons Corp (PSN) plunged 40.5% to $36.91 intraday, triggering brief volatility halts, after the company reported a disappointing second quarter, announced $118 million of non-recurring charges and sharply trimmed full-year 2026 guidance. The market is reassessing the firm's near-term outlook following an EPS shortfall, a GAAP net loss, and a down…